Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a breakthrough chiral rhodium-catalyzed method for carbon-nitrogen axial chiral indole-naphthol compounds with 96%ee, mild conditions, and high yield. Reduce R&D costs and supply chain risks for your API synthesis.
Eliminate palladium catalysts and anhydrous conditions in vismodegib production. Achieve 99% purity with 50% yield using copper-catalyzed route. Reduce costs by 30%.
Eliminate heavy metal catalysts in 2-trifluoromethyl quinoline synthesis. Our metal-free, air-stable process reduces supply chain risks and costs for pharmaceutical intermediates.
Discover a metal-free, air-tolerant synthesis for trifluoroacetimide dihydrobenzofuran compounds. Eliminate heavy metal catalysts and nitrogen protection to reduce costs and improve supply chain reliability for pharmaceutical intermediates.
Solve hydrogenation and iron contamination issues in aminopyrimidine synthesis. Our CDMO expertise delivers high-yield, GMP-compliant production for non-small cell lung cancer therapeutics.
Discover a green, high-yield synthesis method for 4-oxo acrylate derivatives using visible light catalysis. Eliminate waste, reduce costs, and ensure supply chain stability for your pharmaceutical intermediates.
Solve low enantioselectivity & high catalyst cost in alpha-hydroxy-beta-keto ester production. 97% ee, 95% yield, 5-25 mol% catalyst. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Recent patent breakthroughs enable high-yield (96%) synthesis of chiral indolo-dihydropyridoindole with >95% ee. Ideal for pharmaceutical R&D and scalable production.
Discover a green, room-temperature amide synthesis method with >90% yields. Eliminate high-temperature risks and costly catalyst separation. Optimize your supply chain today.
Discover how metal-free, heating-promoted synthesis of 5-trifluoromethyl-1,2,4-triazole reduces GMP compliance risks and cuts production costs for pharmaceutical intermediates. Scale-ready solution.
Solve metal-catalyst dependency in naproxen synthesis. 88% yield, no anhydrous conditions. Secure supply chain for pharma R&D and production.
Discover scalable synthesis of N-N axis chiral pyrrole derivatives with >94% ee and high QGP-1 cytotoxicity. Eliminate costly chiral separation steps. Request COA/MSDS now.
Solve low-yield C-C coupling challenges with this novel Pd catalyst. 99% yield in Suzuki-Miyaura reactions, reducing production costs and supply risks for API manufacturing.
83% yield, catalyst recyclability, and water-only byproduct in quinoline synthesis. Reduce solvent costs and EHS risks for pharma intermediates. Contact for CDMO solutions.
Discover how rhodium-catalyzed C-H activation enables cost-effective, gram-scale production of trifluoromethylated indole intermediates with high functional group tolerance for drug development.
Discover how cobalt-catalyzed C-H activation enables efficient indole carboxamide production for pharma R&D. Reduce costs and supply chain risks with scalable, high-yield routes.
Discover a novel, high-yield iodination/sulfonylation method for 1,6-dienes using air atmosphere and CuI. Reduce production costs and improve supply chain stability for your pharmaceutical intermediates.
Discover how metal-free visible light catalysis enables high-yield, enantioselective synthesis of chiral alpha-azaarene compounds for drug development. Reduce production costs and supply chain risks.
Solve amide synthesis challenges with metal-free NHC catalysis: 93-96% yields, 15-min reactions, no metal residues. Reduce costs and supply chain risks for pharma intermediates.
Discover how recent photocatalytic synthesis of beta-chloroesters eliminates pre-functionalization needs, reduces supply chain risks, and achieves >60% yields for pharmaceutical intermediates.